Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy
Practice Guideline, March 2015
Read Published ArticleThe objective of this guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of the currently available literature.
Reaffirmed on July 12, 2024.
Co-developed with the American Association of Neuromuscular & Electrodiagnostic Medicine.
Endorsed by the American Academy of Pediatrics, the American Occupational Therapy Association, the Child Neurology Society, and the National Association of Neonatal Nurses.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Educational Materials
Other resources related to this guideline
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.
Patient Summary Translation
Translated in Spanish (Español)
Patient Summary Translation
Translated in Korean (한국어)